HeartSciences (HSCSW) Change in Receivables (2022 - 2025)
HeartSciences (HSCSW) reported Change in Receivables of -$4350.0 for Q3 2025, down 200.0% quarter-over-quarter from $4350.0 in Q2 2025.
HeartSciences (HSCSW) Change in Receivables (2022 - 2025) Analysis & Trends
HeartSciences has reported Change in Receivables for 3 years, with the latest figure at -$4350.0 in Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables changed N/A year-over-year to -$4350.0; the trailing twelve-month figure through Oct 2025 stood at $10800.0 (changed N/A YoY), and the FY2025 full-year result was $4350.0, changed N/A from the prior year.
- Change in Receivables for Q3 2025 stood at -$4350.0, down from $4350.0 in the prior quarter.
- The five-year high for Change in Receivables was $10800.0 in Q1 2024, with the low at -$4350.0 in Q3 2025.
- Historically, Change in Receivables has averaged $2119.8 across 3 years, with a median of $1014.5 in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | HeartSciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -4,350.00 |
| Jul 31, 2025 | -4,350.00 |
| Apr 30, 2025 | 4,350.00 |
| Apr 30, 2025 | 4,350.00 |
| Jan 31, 2024 | 10,800.00 |
| Jan 31, 2024 | 10,800.00 |
| Jul 31, 2022 | -2,321.00 |
| Jul 31, 2022 | -2,321.00 |